Home  >  News
Msc_Apr23 Advertisement
you can get e-magazine links on WhatsApp. Click here
  Statement on the antigen composition of Covid-19 vaccines,   May 22, 2023
  US FDA committee votes in support of approval for Pfizer’s vaccine candidate to help prevent RSV in infants through maternal immunization,   May 20, 2023
  Siren Biotechnology launches to pioneer Universal AAV Immuno-Gene Therapy for cancer,   May 18, 2023
  Access to Novavax's Covid vaccine grows with extended interim authorization for adolescents in Singapore,   May 15, 2023
  Nona Biosciences collaborates with PharmaEssentia for Nona’s Harbour Mice fully human antibody transgenic mice platform,   May 13, 2023
  Scientists release a new human “pangenome” reference,   May 12, 2023
  TechInvention launches Euvichol-Plus, the world’s first and only oral cholera vaccine in an LDPE unidose pack, in India,   May 12, 2023
  Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing,   May 12, 2023
  Sandoz enters multi-year partnership with Just - Evotec Biologics to develop and manufacture multiple biosimilars,   May 11, 2023
  US FDA approves GSK’s respiratory syncytial virus vaccine, Arexvy for older adults,   May 05, 2023
  ImaginAb, Quibim partner to revolutionize immune status diagnosis and immunotherapy prediction,   May 03, 2023
  Pfizer’s 20-valent Pneumococcal Conjugate Vaccine, Prevnar 20 receives US FDA approval for prevention of IPD in infants and children,   April 29, 2023
  GSK launches shingles vaccine, Shingrix in India,   April 28, 2023
  Bristol Myers Squibb strengthens cell therapy capabilities by adding new US manufacturing facility for viral vector production,   April 28, 2023
  EMA committee recommends approval of GSK’s respiratory syncytial virus for prevention of LRTD caused by RSV in adults aged 60 years and older,   April 28, 2023
  AmerisourceBergen launches CGT Integration Hub,   April 27, 2023
  Global partners announce a new effort – “The Big Catch-up” – to vaccinate millions of children and restore immunization progress lost during the pandemic,   April 26, 2023
  InSilicoTrials, AchilleS Vaccines join forces to create next-generation vaccines and monoclonal antibodies against infectious diseases,   April 22, 2023
  mRNA Technology Transfer Programme moves to the next phase of its development,   April 21, 2023
  US FDA approves Gamida Cell’s allogeneic cell therapy, Omisirge,   April 19, 2023

Copyright © 2016 Saffron Media Pvt. Ltd |